Growth factors present in human breast milk may protect against intestinal damage
The Medical News,
Studies Suggest that ErbB4 Receptor Activation May Be a Novel Therapeutic Avenue for Intestinal Diseases Involving Epithelial…
Studies Suggest that ErbB4 Receptor Activation May Be a Novel Therapeutic Avenue for Intestinal Diseases Involving Epithelial…
Growth factors present in human breast milk, but not in formula, may explain the protection against intestinal damage due to…
Philadelphia, PA, September 9, 2014 – Necrotizing enterocolitis (NEC) is a devastating gastrointestinal illness affecting up to…
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal illness affecting up to 10% of premature infants, with a 30…